Mannkind Corporation (MNKD) Dividend History

Mannkind Corporation is a biotechnology company focused on discovering, developing, and commercializing inhaled therapeutic products. It is best known for its flagship product, Afrezza, an inhalable insulin used to improve blood sugar control in people with diabetes. The company also develops other inhaled and injectable drug delivery systems aimed at providing innovative solutions for various medical conditions.

1 Casper Street, Danbury, CT, 06810
Phone: 818-661-5000
Website: https://www.mannkindcorp.com

Dividend History

Mannkind Corporation currently does not pay dividends

Company News

  • A Phase 4 study found that more adults with type 1 diabetes achieved target A1C levels when switching from multiple daily injections or insulin pumps to inhaled insulin (Afrezza). The data showed continued improvement in glycemic control for those who remained on Afrezza or switched to it.

    GlobeNewswire Inc.
  • MannKind's long-term liabilities exceed its assets, posing potential financial risks. Learn why MNKD stock is a Buy.

    Seeking Alpha
    Featured Companies: LQDA MRK UTHR
  • MannKind (MNKD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

    Zacks Investment Research
  • Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450. TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share. Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business. Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620. Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024. EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024. Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company. Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision ...

    Benzinga
Page data last updated 07/23/2025 16:06:29 UTC